Santa Clara California based Rebus Biosystems is raising $32,262,694.00 in New Equity Investment.
Santa Clara, CA – According to filings with the U.S. Securities and Exchange Commission, Rebus Biosystems is raising $32,262,694.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Eric Williams played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Rebus Biosystems
At Rebus Biosystems, our vision is spatial omics without compromise. Get subcellular resolution of biological molecules directly in and across large tissue sections. Customizable assays allow you to focus on the targets that matter most to your research. Available as a fully automated, integrated instrument for your lab in early 2021. Get access now available through our Spatial Omics as a Service program. The Rebus Esper is a fully integrated, automated instrument that delivers high-throughput, quantitative, single-molecule, single-cell data with spatial context and subcellular resolution by bringing together advancements in imaging, fluidics, chemistry and bioinformatics.
To learn more about Rebus Biosystems, visit http://rebusbio.com/
Contact:
Eric Williams, Chief Financial Officer
408-988-2700
https://www.linkedin.com/in/eric-williams-b16101/
SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved